|
Professional-Patient Relations
|
D011369 |
[Interactions between health personnel and patients.
] |
|
Professionalism
|
D000068616 |
[The level of skill, good judgment, and polite behavior expected from people trained to do their jobs well.
] |
|
Profilins
|
D051304 |
[A family of low molecular weight proteins that bind ACTIN and control actin polymerization. They are found in eukaryotes and are ubiquitously expressed.
] |
|
Proflavine
|
D011370 |
[Topical antiseptic used mainly in wound dressings.
] |
|
Progeria
|
D011371 |
[An abnormal congenital condition, associated with defects in the LAMIN TYPE A gene, which is characterized by premature aging in children, where all the changes of cell senescence occur. It is manifested by premature graying; hair loss; hearing loss (DEAFNESS); cataracts (CATARACT); ARTHRITIS; OSTEOPOROSIS; DIABETES MELLITUS; atrophy of subcutaneous fat; skeletal hypoplasia; elevated urinary HYALURONIC ACID; and accelerated ATHEROSCLEROSIS. Many affected individuals develop malignant tumors, especially SARCOMA.
] |
|
Progesterone
|
D011374 |
[The major progestational steroid that is secreted primarily by the CORPUS LUTEUM and the PLACENTA. Progesterone acts on the UTERUS, the MAMMARY GLANDS and the BRAIN. It is required in EMBRYO IMPLANTATION; PREGNANCY maintenance, and the development of mammary tissue for MILK production. Progesterone, converted from PREGNENOLONE, also serves as an intermediate in the biosynthesis of GONADAL STEROID HORMONES and adrenal CORTICOSTEROIDS.
] |
|
Progesterone Congeners
|
D045167 |
[Steroidal compounds related to PROGESTERONE, the major mammalian progestational hormone. Progesterone congeners include important progesterone precursors in the biosynthetic pathways, metabolites, derivatives, and synthetic steroids with progestational activities.
] |
|
Progesterone Reductase
|
D011375 |
[An enzyme that catalyzes the reduction of a 3 beta-hydroxy-delta(5)-steroid to 3-oxo-delta(4)-steroid in the presence of NAD. It converts pregnenolone to progesterone and dehydroepiandrosterone to androstenedione. EC 1.1.1.145.
] |
|
Progesterone-Binding Globulin
|
D011376 |
[A glycoprotein migrating as alpha 1-globulin, molecular weight 70,000 to 120,000. The protein, which is present in increased amounts in the plasma during pregnancy, binds mainly progesterone, with other steroids including testosterone competing weakly.
] |
|
Progestins
|
D011372 |
[Compounds that interact with PROGESTERONE RECEPTORS in target tissues to bring about the effects similar to those of PROGESTERONE. Primary actions of progestins, including natural and synthetic steroids, are on the UTERUS and the MAMMARY GLAND in preparation for and in maintenance of PREGNANCY.
] |
|
Proglucagon
|
D052336 |
[The common precursor polypeptide of pancreatic GLUCAGON and intestinal GLUCAGON-LIKE PEPTIDES. Proglucagon is the 158-amino acid segment of preproglucagon without the N-terminal signal sequence. Proglucagon is expressed in the PANCREAS; INTESTINES; and the CENTRAL NERVOUS SYSTEM. Posttranslational processing of proglucagon is tissue-specific yielding numerous bioactive peptides.
] |
|
Proglumide
|
D011377 |
[A drug that exerts an inhibitory effect on gastric secretion and reduces gastrointestinal motility. It is used clinically in the drug therapy of gastrointestinal ulcers.
] |
|
Prognathism
|
D011378 |
[A condition marked by abnormal protrusion of the mandible. (Dorland, 27th ed)
] |
|
Prognosis
|
D011379 |
[A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations.
] |
|
Program
|
D019542 |
[Works consisting of lists of the events, pieces, performers, speakers, etc., of an entertainment, ceremony, or the like. (From: Genre Terms: A Thesaurus for Use in Rare Book and Special Collections Cataloging, 2d ed)
] |
|
Program Development
|
D016730 |
[The process of formulating, improving, and expanding educational, managerial, or service-oriented work plans (excluding computer program development).
] |
|
Program Evaluation
|
D015397 |
[Studies designed to assess the efficacy of programs. They may include the evaluation of cost-effectiveness, the extent to which objectives are met, or impact.
] |
|
Programmed Cell Death 1 Ligand 2 Protein
|
D061027 |
[A costimulatory B7 antigen that has specificity for the T-CELL receptor PROGRAMMED CELL DEATH 1 RECEPTOR. It is closely-related to CD274 antigen; however, its expression is restricted to DENDRITIC CELLS and activated MACROPHAGES.
] |
|
Programmed Cell Death 1 Receptor
|
D061026 |
[An inhibitory T-lymphocyte receptor that has specificity for CD274 ANTIGEN and PROGRAMMED CELL DEATH 1 LIGAND 2 PROTEIN. Signaling by the receptor limits T cell proliferation and INTERFERON GAMMA synthesis. The receptor also may play an essential role in the regulatory pathway that induces PERIPHERAL TOLERANCE.
] |
|
Programmed Instruction
|
D020498 |
[Works consisting of sequenced self-correction texts.
] |
